share_log

BTIG Initiates Coverage On Xtant Medical Hldgs With Buy Rating, Announces Price Target of $2

Benzinga ·  Dec 5, 2023 08:40

BTIG analyst Ryan Zimmerman initiates coverage on Xtant Medical Hldgs (AMEX:XTNT) with a Buy rating and announces Price Target of $2.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment